EBM Technologies (ROCO:8409) ROCE %: 42.05% (As of Dec. 2025)

What is EBM Technologies ROCE %?

EBM Technologies ROCO:8409 64 ROCE % is 42.05% as of Dec. 2025. GuruFocus rates ROCO:8409 with a GF Score™ of 64/100 and a GF Value™ of NT$25.74 (Modestly Undervalued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. EBM Technologies's annualized ROCE % for the quarter that ended in Dec. 2025 was 42.05%.

EBM Technologies (ROCO:8409) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

EBM Technologies ROCE % Related Terms

EBM Technologies ROCE % Historical Data

* Premium members only.

The historical data trend for EBM Technologies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EBM Technologies ROCE % Chart

EBM Technologies Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

-7.10

2.76

-3.15

2.72

4.71

EBM Technologies Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25
ROCE %	Get a 7-Day Free Trial															97.38	-31.24	-28.75	38.28	42.05

64GF Score

EBM Technologies Inc ROCO:8409

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

EBM Technologies ROCE % Calculation

EBM Technologies's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	15.273	/	( ( (559.669 - 237.364)	+	(436.022 - 109.263) )	/ 2 )
	=	15.273	/	( (322.305	+	326.759)	/ 2 )
	=	15.273	/	324.532
	=	4.71 %

EBM Technologies's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2025 )		(Q: Sep. 2025 )		(Q: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2025 )		(Q: Sep. 2025 )		(Q: Dec. 2025 )
	=	131.32	/	( ( (440.565 - 142.696)	+	(436.022 - 109.263) )	/ 2 )
	=	131.32	/	( ( 297.869	+	326.759 )	/ 2 )
	=	131.32	/	312.314
	=	42.05 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 42.05% mean?

EBM Technologies (ROCO:8409) has a ROCE % of 42.05% as of Dec. 2025.

Is EBM Technologies' ROCE % too high?

EBM Technologies' current ROCE % is 42.05%. The Healthcare Providers & Services industry median ROCE % is 6.41. EBM Technologies' value of 42.05% is 556% above this industry median. Overall, EBM Technologies has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does EBM Technologies' ROCE % compare to VEEV and BTSG?

EBM Technologies' ROCE % of 42.05% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. EBM Technologies' value of 42.05% is 556% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Healthcare Providers & Services company?

The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 644 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EBM Technologies's current ROCE % of 42.05% is 556% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EBM Technologies's current ROCE % is 42.05%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is EBM Technologies stock overvalued right now?

Based on GuruFocus' analysis, EBM Technologies (ROCO:8409) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$25.74, compared to a current price of NT$19.10 — trading 25.8% below its estimated fair value. The current ROCE % is 42.05% and 556% above the Healthcare Providers & Services industry median of 6.41. EBM Technologies' overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For EBM Technologies (ROCO:8409), the current ROCE % is 42.05% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is EBM Technologies (ROCO:8409) Overvalued in 2026?

Based on GuruFocus' analysis, EBM Technologies stock appears to be undervalued. The current stock price of NT$19.10 is trading 25.8% below its estimated GF Value™ of NT$25.74. GuruFocus considers EBM Technologies to be Modestly Undervalued.

Key valuation signals for ROCO:8409:

ROCE %: 42.05%
GF Value™: NT$25.74 vs. price of NT$19.10 (25.8% below fair value)
GF Score™: 64/100 with 4 warning signs
Industry Position: 556% above the Healthcare Providers & Services median

No single metric tells the full story. See the ROCO:8409 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

EBM Technologies Business Description

Industry Healthcare Healthcare Providers & Services

Comparable Companies ROCO:6857 VEEV ASX:PME BTSG TEM HQY TSE:2413 HNGE TXG DOCS WAY HKSE:02228 PRVA HTFL NSE:IKS SZSE:300253 NSE:SAGILITY OMCL HKSE:01833 TDOC

Address No. 516, Sec 1, Neihu Road, 5th floor, Neihu District, Taipei, TWN

Website https://www.ebmtech.com

EBM Technologies Inc is engaged in picture archiving and communication systems. Its products include EBM diagnostic and reviewing station, EBM storage and utility server, and EBM breast imaging for PACS. The company develops and markets medical information technology solutions; and provides to the health sector.

64GF Score

Get the complete analysis for ROCO:8409

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$19.10

Price

NT$25.74

GF Value

View ROCO:8409 Analysis

See ROCE % data for all stocks →